Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 151 AL 165

The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer's Cholinergic Atrophy

Do Carmo S, Kannel B, Cuello AC.

Cells. 2021 Dec 22;11(1):16. doi: 10.3390/cells11010016.

Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease

Hüttenrauch M, Lopez-Noguerola JS, Castro-Obregón S.

J Alzheimers Dis. 2021;82(s1):S65-S90. doi: 10.3233/JAD-200743.

Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review

Tuena C, Mancuso V, Stramba-Badiale C, Pedroli E, Stramba-Badiale M, Riva G, Repetto C.

J Alzheimers Dis. 2021;79(1):95-116. doi: 10.3233/JAD-201017.

Implementing Delirium Prevention in the Era of COVID-19

Radhakrishnan NS, Mufti M, Ortiz D, Maye ST, Melara J, Lim D, Rosenberg EI, Price CC.

J Alzheimers Dis. 2021;79(1):31-36. doi: 10.3233/JAD-200696.

The utility of olfactory function in distinguishing early-stage Alzheimer's disease from HIV-associated neurocognitive disorders

Sundermann EE, Fields A, Saloner R, Gouaux B, Bharti A, Murphy C, Moore DJ.

AIDS. 2021 Mar 1;35(3):429-437. doi: 10.1097/QAD.0000000000002761.

Analysis of Risk Factors in Dementia Through Machine Learning

Balea-Fernandez FJ, Martinez-Vega B, Ortega S, Fabelo H, Leon R, Callico GM, Bibao-Sieyro C.

J Alzheimers Dis. 2021;79(2):845-861. doi: 10.3233/JAD-200955.

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment

Pyun JM, Ryoo N, Park YH, Kim S.

Alzheimers Res Ther. 2021 Jan 5;13(1):10. doi: 10.1186/s13195-020-00749-5.

Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review

Lu Y, Liu C, Yu D, Fawkes S, Ma J, Zhang M, Li C.

BMC Geriatr. 2021 Jan 6;21(1):10. doi: 10.1186/s12877-020-01948-3.

Arterial Changes Connecting Hypertension to Alzheimer's Disease and Related Dementias

Burke GL, Hughes TM.

JACC Cardiovasc Imaging. 2021 Jan;14(1):186-188. doi: 10.1016/j.jcmg.2020.10.018.

Preservation of Memory in Alzheimer-Related Primary Progressive Aphasia: Glass Half Full

Sajjadi SA, Ash S, Cappa S.

Neurology. 2021 Feb 9;96(6):243-244. doi: 10.1212/WNL.0000000000011404. Epub 2021 Jan 13.

The Fragility of Temporal Memory in Alzheimer's Disease

Park JH, Lee SA.

J Alzheimers Dis. 2021;79(4):1631-1646. doi: 10.3233/JAD-200892.

Connecting vascular aging and frailty in Alzheimer's disease

Sabbatinelli J, Ramini D, Giuliani A, Recchioni R, Spazzafumo L, Olivieri F.

Mech Ageing Dev. 2021 Apr;195:111444. doi: 10.1016/j.mad.2021.111444. Epub 2021 Feb 1.

Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes

Köbe T, Binette AP, Vogel JW, Meyer PF, Breitner JCS, Poirier J, Villeneuve S; Presymptomatic Evaluation of Novel or Experimental Treatments for Alzheimer Disease (PREVENT-AD) Research Group.

Neuroimage. 2021 May 1;231:117832. doi: 10.1016/j.neuroimage.2021.117832. Epub 2021 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias